Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure and function of decay accelerating factor CD55

A Nicholson-Weller1, C E Wang

  • 1Charles A. Dana Research Institute, Harvard-Thorndike Laboratories, Boston, MA.

The Journal of Laboratory and Clinical Medicine
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[HIV infection status and characteristics of non-remunerated blood donors in Hangzhou, 2008-2017].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2019
Same author

[Study on the mechanism of serotype conversion of historical isolates of <i>Shigella flexneri</i>].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2018
Same author

Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Positive selection sites in tertiary structure of Leguminosae chalcone isomerase 1.

Genetics and molecular research : GMR·2015
Same author

Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge.

Indian journal of cancer·2015
Same author

Transcatheter arterial embolization of acute gastrointestinal tumor hemorrhage with Onyx.

Indian journal of cancer·2015
Same journal

Studies on streptomycin; assay in body fluids.

The Journal of laboratory and clinical medicine·2010
Same journal

Gastrocolic fistula; an experimental study.

The Journal of laboratory and clinical medicine·2010
Same journal

An isolated heart perfusion system adapted to the determination of nongaseous metabolities; with sample data upon the isolated monkey heart.

The Journal of laboratory and clinical medicine·2010
Same journal

A new type of glass cage for metabolism studies.

The Journal of laboratory and clinical medicine·2010
Same journal

A simple electrocardiograph contact electrode for use with the smaller laboratory animal.

The Journal of laboratory and clinical medicine·2010
Same journal

A primary standard for the colorimetric determination of hemoglobin.

The Journal of laboratory and clinical medicine·2010
See all related articles

Decay-accelerating factor (DAF) regulates complement activation, particularly C3 deposition on cells. Its structure involves short consensus repeats, with the third repeat crucial for its function and signaling via associated tyrosine kinases.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Decay-accelerating factor (DAF) is a complement regulatory protein.
  • DAF acts as a species restricting factor at the C3/C5 activation level.

Purpose of the Study:

  • To review the function and structure of decay-accelerating factor (DAF).
  • To discuss the therapeutic potential of DAF.

Main Methods:

  • Gene cloning to understand DAF structure.
  • Review of existing studies on DAF function and signaling.

Main Results:

  • DAF possesses four short consensus repeats, characteristic of regulators of complement activation.
  • The third short consensus repeat mediates DAF's complement regulatory activity and signaling.

Related Experiment Videos

  • DAF is associated with tyrosine kinases, likely involved in its signaling pathway.
  • DAF plays a key role in regulating C3 deposition on nucleated cells, not erythrocyte hemolysis.

    • Conclusions:

    • DAF's structure, particularly the third SCR, is key to its regulatory function.
    • DAF signaling involves GPI anchor association with tyrosine kinases, though the exact mechanism is unclear.
    • DAF has significant therapeutic potential due to its role in complement regulation.